BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 34405378)

  • 1. Hormonal treatments for endometriosis: The endocrine background.
    Vannuccini S; Clemenza S; Rossi M; Petraglia F
    Rev Endocr Metab Disord; 2022 Jun; 23(3):333-355. PubMed ID: 34405378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure.
    Reis FM; Coutinho LM; Vannuccini S; Batteux F; Chapron C; Petraglia F
    Hum Reprod Update; 2020 Jun; 26(4):565-585. PubMed ID: 32412587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor ligands for the treatment of endometriosis.
    Clemenza S; Capezzuoli T; Eren E; Garcia Garcia JM; Vannuccini S; Petraglia F
    Minerva Obstet Gynecol; 2023 Jun; 75(3):288-297. PubMed ID: 36255163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
    Clemenza S; Sorbi F; Noci I; Capezzuoli T; Turrini I; Carriero C; Buffi N; Fambrini M; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():92-101. PubMed ID: 29559388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
    Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
    Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovations in classical hormonal targets for endometriosis.
    Pluchino N; Freschi L; Wenger JM; Streuli I
    Expert Rev Clin Pharmacol; 2016; 9(2):317-27. PubMed ID: 26645363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of inflammation and aromatase expression in the eutopic endometrium and its relationship with the development of endometriosis.
    Maia H; Haddad C; Coelho G; Casoy J
    Womens Health (Lond); 2012 Nov; 8(6):647-58. PubMed ID: 23181530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of phase II and III drugs for the treatment and management of endometriosis.
    Perrone U; Evangelisti G; Laganà AS; Bogliolo S; Ceccaroni M; Izzotti A; Gustavino C; Ferrero S; Barra F
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):333-351. PubMed ID: 38099328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and Emerging Therapeutics for the Management of Endometriosis.
    Ferrero S; Barra F; Leone Roberti Maggiore U
    Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is aromatase expression in the endometrium the cause of endometriosis and related infertility?
    Maia H; Casoy J; Valente Filho J
    Gynecol Endocrinol; 2009 Apr; 25(4):253-7. PubMed ID: 19340622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Management of Endometriosis.
    Rafique S; Decherney AH
    Clin Obstet Gynecol; 2017 Sep; 60(3):485-496. PubMed ID: 28590310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovations in conservative endometriosis treatment: an updated review.
    Ruhland B; Agic A; Krampe J; Diedrich K; Hornung D
    Minerva Ginecol; 2011 Jun; 63(3):247-59. PubMed ID: 21654610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors: the next generation of therapeutics for endometriosis?
    Attar E; Bulun SE
    Fertil Steril; 2006 May; 85(5):1307-18. PubMed ID: 16647373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
    Liang B; Wu L; Xu H; Cheung CW; Fung WY; Wong SW; Wang CC
    Reprod Biol Endocrinol; 2018 Apr; 16(1):32. PubMed ID: 29615065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain.
    Bedaiwy MA; Allaire C; Yong P; Alfaraj S
    Semin Reprod Med; 2017 Jan; 35(1):38-53. PubMed ID: 28002850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of endometriosis.
    Huang HY
    Chang Gung Med J; 2008; 31(5):431-40. PubMed ID: 19097589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.